tiprankstipranks
United-Guardian (UG)
NASDAQ:UG
US Market
Want to see UG full AI Analyst Report?

United-Guardian (UG) Price & Analysis

162 Followers

UG Stock Chart & Stats

$6.22
-$0.09(-0.84%)
At close: 4:00 PM EST
$6.22
-$0.09(-0.84%)

Bulls Say, Bears Say

Bulls Say
Debt-free Balance SheetZero reported debt provides durable financial flexibility: it lowers insolvency risk, preserves capacity to fund operations, dividends or opportunistic M&A, and allows the company to absorb demand shocks over the next several months without reliance on external financing.
High-quality Cash ConversionConsistent conversion of earnings into cash indicates high-quality profits and supports recurring shareholder returns and reinvestment. Over a 2–6 month horizon this underpins capital allocation flexibility, lowers refinancing risk, and sustains operational funding needs.
Robust Gross And Net MarginsElevated margins reflect specialty, value-added ingredients with pricing power and scalable manufacturing. Sustained margin levels support healthy cash generation and returns on capital, providing a structural cushion through modest demand volatility.
Bears Say
Choppy Revenue GrowthIrregular top-line performance reduces visibility for planning and constrains reliable growth expectations. Over the medium term this can limit reinvestment, make budgeting for R&D or capacity expansion harder, and leave returns dependent on cyclical personal-care demand.
Variable Free Cash FlowYear-to-year cash flow swings weaken predictability of funding for dividends, capex, or buybacks. Even with strong aggregate conversion, intermittent negative years raise the risk that discretionary investments or payouts may need trimming during downturns or unexpected cost shocks.
Small Scale And Concentrated End-marketsLimited scale and reliance on personal-care formulations make UG more exposed to customer loss, product shifts, and competitive pressures. Smaller operational footprint constrains R&D breadth and distribution reach, reducing resilience versus larger, diversified suppliers.

United-Guardian News

UG FAQ

What was United-Guardian’s price range in the past 12 months?
United-Guardian lowest stock price was $5.58 and its highest was $9.88 in the past 12 months.
    What is United-Guardian’s market cap?
    United-Guardian’s market cap is $32.57M.
      When is United-Guardian’s upcoming earnings report date?
      United-Guardian’s upcoming earnings report date is Aug 07, 2026 which is in 76 days.
        How were United-Guardian’s earnings last quarter?
        United-Guardian released its earnings results on May 08, 2026. The company reported $0.178 earnings per share for the quarter, beating the consensus estimate of N/A by $0.178.
          Is United-Guardian overvalued?
          According to Wall Street analysts United-Guardian’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does United-Guardian pay dividends?
            United-Guardian pays a Semiannually dividend of $0.25 which represents an annual dividend yield of 9.81%. See more information on United-Guardian dividends here
              What is United-Guardian’s EPS estimate?
              United-Guardian’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does United-Guardian have?
              United-Guardian has 4,594,319 shares outstanding.
                What happened to United-Guardian’s price movement after its last earnings report?
                United-Guardian reported an EPS of $0.178 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.857%.
                  Which hedge fund is a major shareholder of United-Guardian?
                  Currently, no hedge funds are holding shares in UG
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    United-Guardian Stock Smart Score

                    6
                    Neutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -43.84%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    21.40%
                    Trailing 12-Months
                    Asset Growth
                    -0.50%
                    Trailing 12-Months

                    Company Description

                    United-Guardian

                    United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

                    United-Guardian (UG) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Acme United
                    Mannatech
                    Beauty Health
                    Grove Collaborative Holdings
                    Yoshitsu Co. Ltd. Sponsored ADR

                    Ownership Overview

                    22.45%6.93%8.98%57.78%
                    22.45% Insiders
                    8.98% Other Institutional Investors
                    57.78% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks